Johan Wejde

2.0k total citations
47 papers, 1.5k citations indexed

About

Johan Wejde is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Johan Wejde has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Johan Wejde's work include Sarcoma Diagnosis and Treatment (23 papers), Plant biochemistry and biosynthesis (9 papers) and Bone Tumor Diagnosis and Treatments (6 papers). Johan Wejde is often cited by papers focused on Sarcoma Diagnosis and Treatment (23 papers), Plant biochemistry and biosynthesis (9 papers) and Bone Tumor Diagnosis and Treatments (6 papers). Johan Wejde collaborates with scholars based in Sweden, United States and Finland. Johan Wejde's co-authors include Olle Larsson, Anica Dricu, Henrik C. F. Bauer, Magnus Karlsson, Lena Kanter‐Lewensohn, Otte Brosjö, Fredrik Mertens, Leonard Girnita, Nils Mandahl and Magnus Hjertman and has published in prestigious journals such as Clinical Cancer Research, Biochemical and Biophysical Research Communications and Journal of Cell Science.

In The Last Decade

Johan Wejde

47 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Wejde Sweden 23 612 587 378 374 210 47 1.5k
Kjetil Boye Norway 25 636 1.0× 1.0k 1.8× 678 1.8× 212 0.6× 587 2.8× 84 2.2k
Diane Kowalski United States 22 351 0.6× 628 1.1× 767 2.0× 132 0.4× 271 1.3× 45 2.0k
Laura Boldrini Italy 27 733 1.2× 1.2k 2.0× 916 2.4× 157 0.4× 652 3.1× 98 2.5k
Robert Nakayama Japan 21 829 1.4× 697 1.2× 496 1.3× 303 0.8× 263 1.3× 82 1.6k
Marie‐Pierre Simon France 21 439 0.7× 1.1k 1.8× 429 1.1× 188 0.5× 555 2.6× 31 1.9k
Stefania Brozzetti Italy 21 307 0.5× 586 1.0× 468 1.2× 106 0.3× 393 1.9× 50 1.6k
Hsuan-Ying Huang Taiwan 30 822 1.3× 1.2k 2.0× 700 1.9× 343 0.9× 434 2.1× 55 2.4k
Irina Linkov United States 15 351 0.6× 531 0.9× 598 1.6× 66 0.2× 275 1.3× 27 1.5k
Christina Selinger Australia 22 726 1.2× 864 1.5× 928 2.5× 77 0.2× 660 3.1× 50 2.1k
Shuko Harada United States 22 293 0.5× 604 1.0× 399 1.1× 61 0.2× 297 1.4× 101 1.4k

Countries citing papers authored by Johan Wejde

Since Specialization
Citations

This map shows the geographic impact of Johan Wejde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Wejde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Wejde more than expected).

Fields of papers citing papers by Johan Wejde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Wejde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Wejde. The network helps show where Johan Wejde may publish in the future.

Co-authorship network of co-authors of Johan Wejde

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Wejde. A scholar is included among the top collaborators of Johan Wejde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Wejde. Johan Wejde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Öfverholm, Ingegerd, Johan Wejde, Valtteri Wirta, et al.. (2024). Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma. Clinical Cancer Research. 30(12). 2647–2658. 4 indexed citations
2.
Lin, Yingbo, Asle C. Hesla, Mehran Ghaderi, et al.. (2018). Telomerase promoter mutations and copy number alterations in solitary fibrous tumours. Journal of Clinical Pathology. 71(9). 832–839. 15 indexed citations
3.
Lin, Yingbo, Yi Chen, Asle C. Hesla, et al.. (2018). hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortality. Modern Pathology. 31(12). 1834–1841. 12 indexed citations
4.
Bjerkehagen, Bodil, Johan Wejde, Magnus Hansson, Henryk A. Domanski, & Tom Böhling. (2009). SSG pathology review experiences and histological grading of malignancy in sarcomas. Acta Orthopaedica. 80(334). 31–36. 6 indexed citations
5.
Åhlén, Jan, Johan Wejde, Otte Brosjö, et al.. (2005). Insulin-Like Growth Factor Type 1 Receptor Expression Correlates to Good Prognosis in Highly Malignant Soft Tissue Sarcoma. Clinical Cancer Research. 11(1). 206–216. 57 indexed citations
6.
Wejde, Johan, et al.. (2004). A Novel Case of Synovial Sarcoma of the Kidney: Impact of SS18/SSX Analysis of Renal Hemangiopericytoma-like Tumors. Diagnostic Molecular Pathology. 13(1). 47–51. 25 indexed citations
7.
Weng, Wen‐Hui, Johan Wejde, Jan Åhlén, et al.. (2004). Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH. Cancer Genetics and Cytogenetics. 150(1). 27–32. 13 indexed citations
8.
Böhling, Tom, Patrizia Bacchini, Francesco Bertoni, et al.. (2004). Diagnosis and tumor response in osteosarcoma and Ewing's sarcoma. Acta Orthopaedica Scandinavica. 75(sup311). 72–76. 3 indexed citations
9.
Dahlén, Anna, Christopher D.�M. Fletcher, Fredrik Mertens, et al.. (2004). Activation of the GLI Oncogene through Fusion with the β-Actin Gene (ACTB) in a Group of Distinctive Pericytic Neoplasms. American Journal Of Pathology. 164(5). 1645–1653. 109 indexed citations
10.
Dahlén, Anna, Fredrik Mertens, Anders Rydholm, et al.. (2003). Fusion, Disruption, and Expression of HMGA2 in Bone and Soft Tissue Chondromas. Modern Pathology. 16(11). 1132–1140. 62 indexed citations
12.
Wang, Min, Yuntao Xie, Leonard Girnita, et al.. (1999). Regulatory Role of Mevalonate and N-Linked Glycosylation in Proliferation and Expression of the EWS/FLI-1 Fusion Protein in Ewing's Sarcoma Cells. Experimental Cell Research. 246(1). 38–46. 27 indexed citations
13.
14.
Nilsson, Gunnar, et al.. (1998). Specific and sensitive detection of the EWS/FLI1 fusion protein in Ewing's sarcoma by Western blotting. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 432(2). 131–134. 13 indexed citations
15.
Nilsson, Gunnar, Min Wang, Johan Wejde, et al.. (1998). Reverse Transcriptase Polymerase Chain Reaction on Fine Needle Aspirates for Rapid Detection of Translocations in Synovial Sarcoma. Acta Cytologica. 42(6). 1317–1324. 18 indexed citations
16.
Kanter‐Lewensohn, Lena, et al.. (1998). Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: a potential therapeutic target. Melanoma Research. 8(5). 389–397. 37 indexed citations
18.
Hjertman, Magnus, Johan Wejde, Anica Dricu, et al.. (1997). Evidence for protein dolichylation. FEBS Letters. 416(3). 235–238. 27 indexed citations
20.
Carlberg, Magdalena, Magnus Hjertman, Johan Wejde, & Olle Larsson. (1994). Mevalonate Is Essential for Growth Activation of Human Fibroblasts: Evidence for a Critical Role of Protein Glycosylation in the Prereplicative Period. Experimental Cell Research. 212(2). 359–366. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026